期刊文献+

高效液相色谱法测定利福布汀的含量 被引量:2

Content Determination of Rifabutin by HPLC
下载PDF
导出
摘要 目的建立测定利福布汀的HPLC方法,并测定市售胶囊制剂中利福布汀的含量。方法以Lichro-spher(100(RP-85.0μm×250mm)为分析柱,乙腈-甲醇-0.04mol/LKH2PO4(54:10:36,v/v)为流动相,流速1ml/min,柱温:40℃,进样量:5.0μl,254nm处紫外检测;对硝基苯酚为内标。结果利福布汀在3.75~150.00μg/ml范围内,峰面积对浓度呈良好的线性关系(r=0.99987),平均回收率为100.24%,RSD为0.90%(n=6)。结论本法简便、快速、准确、灵敏度高、重现性好,适用于利福布汀的质量控制和临床血药浓度的监测。 Objective To establish HPLC mathod for the content determination of rifabution. Methods Using p - nitrophenol as the internal standard, Lichrospher 100 ( RP - 8 5.0μm ×250mm) column was used and the mobile phase consisted of acetonitrile - methanol - 0. 04mol/L KH2PO4 (54 : 10 : 36, v/v) with the flow rate of 1.0ml/min. The column temperature was set at 40℃, the injection volume was 5. 0μl and the detection wavelength was 254nm. Results The linear range of rafibution was 3.75 - 150. 00μgomL - 1 (r = 0. 99987) with an average recovery of 100. 24% ( RSD = 0. 89%, n = 6). Conclusion The method is simple, rapid, accurate and sensitive for the content determination of rifabutin in the quality control and the clincal monitoring.
出处 《临床合理用药杂志》 2011年第05X期80-81,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 利福布汀 高效液相色谱法 HPLC Rifabutin Content determination HPLC
  • 相关文献

参考文献5

二级参考文献6

共引文献8

同被引文献14

  • 1Schiffelers RM, Bakker-Woudenberg IA. Innovations in liposomal formulations for antimicrobial therapy[J]. Expert Opin TherPat, 2003,13(8) : 1 127. 被引量:1
  • 2Hu Y, Jiang X, Ding Y, et al. Preparation and drug relea- se behaviors of nimodipine-loaded poly (caprolactone)- poly (ethylene oxide)-polylactide amphiphilic copolymer nanoparticles[J]. Biomaterials, 2003, 24(13) : 2 395. 被引量:1
  • 3Pandey R, Zahoor A, Sharma S, et al. Nanoparticle en- capsulated antitubercular drugs as a potential oral drug de- livery system against murine tuberculosis[J]. Tuberculo- sis, 2003,83(6) :373. 被引量:1
  • 4Murakami H, Kobayashi M, Takeuchi H, et al. Further application of a modified spontaneous emulsification sol- vent diffusion method to various types of PLGA and PLA polymers for preparati on of nanoparticles[J]. Powder Tech,2000,107(1-2) : 137. 被引量:1
  • 5Murakami H, Kobayashi M, Takeuchi H, et al. Preparati- on of poly (DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method[J]. IntJPharm, 1999, 187(2) : 143. 被引量:1
  • 6Nimje N, Agarwal A, Saraogi GK, et al. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting [J]. J Drug Target, 2009,17(10) :777. 被引量:1
  • 7Barrow EL, Barrow WW, Quenelle DV, et al. Efficacy of rifabutin-loaded microspheres for treatment of Myco- bacterium avium-infected macrophages and mice[J]. Drug Deliv, 2007,14(3) : 119. 被引量:1
  • 8Gaspar MM, Cruz A, Penha AF, et al. Rifabutin encap- sulated in liposomes exhibits increased therapeutic activi- ty in a model of disseminated tuberculosis[J]. Int JAntimi- crob Agents, 2008, 31 ( 1 ) :37. 被引量:1
  • 9Nighute AB , Bhise SB. Preparation and evaluation of ri- fabutin loaded polymeric microspheres[J]. Research Jour- nal Pharmacy and Technology, 2009,2 ( 2 ) : 371. 被引量:1
  • 10于守汎.利福布汀的药效学和药物动力学特点[J].国外医药(抗生素分册),2000,21(6):262-265. 被引量:19

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部